https://researchpepnews.com/articles/glp1-slow-responders-first-weeks-weight-loss Research Pep News en 2026-07-30 Why Am I Not Losing Weight Yet? What GLP-1 Trials Say About Slow Responders https://researchpepnews.com/images/editorial/glp1-slow-response-clinic-review.png A clinician and patient review a gradual weight trend during an obesity-medicine follow-up. Early response to GLP-1-based treatment is evaluated over time while introductory doses are used to build tolerability. Image: Research Pep News. https://researchpepnews.com/articles/eli-lilly-retatrutide-12-year-biologic-exclusivity Research Pep News en 2026-07-29 Retatrutide — Will It Cost $1,500 per Month? https://researchpepnews.com/images/editorial/retatrutide-manufacturing-expansion.png Cranes and construction crews surround a large injectable-medicine manufacturing complex. Lilly says its planned $3.5 billion Pennsylvania plant will produce retatrutide and form part of a $27 billion four-site U.S. expansion. Image: Research Pep News. https://researchpepnews.com/articles/hims-pulls-49-compounded-semaglutide-pill Research Pep News en 2026-07-29 Novo Nordisk Sued Hims & Hers Over a $49 ‘Wegovy Copy’—Then They Made a Deal https://researchpepnews.com/images/editorial/hims-wegovy-tablet-packaging-line.png Wegovy 25 mg semaglutide tablet cartons move through a pharmaceutical packaging line. Image: Research Pep News.